SummitTX Capital, L.P.

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 2052310 FORT WORTH, TX

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,262,793

+$795,257 QoQ

Shares Held

27,151

+200.2% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#125

of 335 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SummitTX Capital, L.P. holds $15,646,022 across 5 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (8.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	134,194	$7,031,765
2	AMLX	Amylyx Pharmaceuticals, Inc.	227,690	$4,089,312
3	PRGO	PERRIGO Co plc	231,555	$2,405,856
4	SUPN	Supernus Pharmaceuticals, Inc. This page	27,151	$1,262,793
5	PBH	Prestige Consumer Healthcare Inc.	18,115	$856,296

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,262,793	27,151	+200.2%	Shares	Sole	2026-08-14
2026-03-31	$467,536	9,045	-22.5%	Shares	Sole	2026-05-15
2025-12-31	$579,999	11,670	+2.7%	Shares	Sole	2026-02-17
2025-09-30	$543,228	11,367	-60.3%	Shares	Defined	2025-11-14
2025-06-30	$903,552	28,666	-19.2%	Shares	Defined	2025-08-14
2025-03-31	$1,162,297	35,490	—	Shares	Defined	2025-05-15
No filing history on record for this holder in this stock.